# Belhaven Biopharma Inc. — Form D

Belhaven Biopharma Inc. of Chapel Hill, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-15. The offering totals $32.3M, of which $32.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-10-15
- Form: D
- Accession: 0001231919-25-000318
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $32.3M
- Amount sold: $32.3M
- Investors: 222
- Date of first sale: 2025-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-560900

## Issuer

- Name: Belhaven Biopharma Inc.
- CIK: 0001873965
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 84406 Winslow, Chapel Hill, NC, 27517
- Phone: 919-656-8658

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Scott David Lyman | Director | Chapel Hill, NC |
| David Algon Neal | Director | Chapel Hill, NC |
| Wes Algon Wheeler | Director | Chapel Hill, NC |
| Derek Algon Winstanly | Director | Chapel Hill, NC |
| Scott David Lyman | Executive Officer | Chapel Hill, NC |
| David Algon Neal | Executive Officer | Chapel Hill, NC |

## More

- [CIK 1873965 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1873965&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000318.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.